Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Animal data with the San Diego company's second-generation ultrasound contrast agent, FS069, were presented at
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury